Citation: P. Szulc et Pd. Delmas, INFLUENCE OF VITAMIN-D AND RETINOIDS ON THE GAMMACARBOXYLATION OF OSTEOCALCIN IN HUMAN OSTEOSARCOMA MG63 CELLS, Bone, 19(6), 1996, pp. 615-620
Citation: P. Szulc et al., SERUM UNDERCARBOXYLATED OSTEOCALCIN IS A MARKER OF THE RISK OF HIP FRACTURE - A 3-YEAR FOLLOW-UP-STUDY, Bone, 18(5), 1996, pp. 487-488
Authors:
SZULC P
ARLOT M
CHAPUY MC
DUBOEUF F
MEUNIER PJ
DELMAS PD
Citation: P. Szulc et al., SERUM UNDERCARBOXYLATED OSTEOCALCIN CORRELATES WITH HIP BONE-MINERAL DENSITY IN ELDERLY WOMEN, Journal of bone and mineral research, 9(10), 1994, pp. 1591-1595
Authors:
KRASSOWSKI J
SZULC P
MAKOWSKA A
GODZIEJEWSKA M
JESKE W
ZGLICZYNSKI S
Citation: J. Krassowski et al., SHORT-TERM PIRENZEPINE TREATMENT IS INEFFECTIVE IN SUPPRESSING 24-H GROWTH-HORMONE SECRETION IN TYPE-1 DIABETES-MELLITUS, Diabetes research and clinical practice, 19(3), 1993, pp. 211-216
Citation: P. Szulc et al., SERUM UNDERCARBOXYLATED OSTEOCALCIN IS A MARKER OF THE RISK OF HIP FRACTURE IN ELDERLY WOMEN, The Journal of clinical investigation, 91(4), 1993, pp. 1769-1774